Wesam Bassiouni

Wesam Bassiouni

Auto-generated profile, based on publicly available information

Wesam Bassiouni

Department of Anesthesiology, Pharmacology and Therapeutics, Djavad Mowafaghian Center for Brain Health, University of British Columbia, Vancouver, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2023 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
BHBridgette Hartley
Bridgette Hartley
WBWesam Bassiouni
Wesam Bassiouni
RSRichard Schulz
Richard Schulz
OJOlivier Julien
Olivier Julien

1 March 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
WBWesam Bassiouni
Wesam Bassiouni
TDTahia Daabees
Tahia Daabees
LLLiliane Louedec
Liliane Louedec
XNXavier Norel
Xavier Norel
ASAmira Senbel
Amira Senbel
Prostaglandins (PGs) play an important role in corpus cavernosum relaxation, as evidenced by alprostadil being used as a drug for erectile dysfunction. Reports about the effect of cyclooxygenase (COX) inhibitors on erectile function are highly contradictory. To compare the potential effects of some COX inhibitors with varying COX-1/COX-2 selectivities (indomethacin, ketoprofen and diclofenac) with that of the selective COX-2 inhibitor (DFU) on corpus cavernosal tone in-vitro. The role played by PGE1, PGI2-analogue and PGE4 receptor (EP4)-agonist in controlling corpus cavernosum function and the modulation of their action by sildenafil is also studied. Organ bath experiments were performed using isolated rat corpus cavernosum. Direct relaxations and changes to electric field stimulation (EFS, 2-16 Hz, 60 V, 0.8 ms, 10 s train)-induced relaxation by the effect of the selected drugs were studied. Strips were precontracted using phenylephrine (PE, 10-5 M). Results are expressed as mean ± SEM of 5-9 rats. Alprostadil, iloprost and L902688 (selective EP4 agonist) induced direct relaxation where L902688 showed greater relaxant effect. Sildenafil potentiated the Emax of alprostadil and iloprost but not L902688. EFS and acetylcholine (ACh)-induced relaxations were significantly potentiated in presence of indomethacin, ketoprofen and diclofenac (20, 100 μM) but not in presence of selective COX-2 inhibitor (DFU, 1 μM). GR32191B (Thromboxane A2 receptor antagonist, 10-6 M) significantly reduced the potentiatory effect of indomethacin. Only diclofenac succeeded to potentiate sodium nitroprusside (SNP)-induced relaxation. EP4 receptors may play an important nitric oxide (NO)/cGMP-independent role in corpus cavernosal relaxation. Nonselective COX inhibitors seem of no harm concerning cavernosal tissue relaxation, possibly because they inhibit the synthesis of the highly contracting mediator thromboxane A2.

20 June 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
PZPavel Zhabyeyev
Pavel Zhabyeyev
BMBrent McLean
Brent McLean
WBWesam Bassiouni
Wesam Bassiouni
RVRobert Valencia
Robert Valencia
MPManish Paul
Manish Paul
GOGavin Oudit
Gavin Oudit
Background: Identifying new therapeutic targets for preventing the myocardial ischemia–reperfusion injury would have profound implications in cardiovascular medicine. Myocardial ischemia–reperfusion injury remains a major clinical burden in patients with coronary artery disease. Methods and Results: We studied several key mechanistic pathways known to mediate cardioprotection in myocardial ischemia–reperfusion in 2 independent genetic models with reduced cardiac phosphoinositide 3‐kinase‐α (PI3Kα) activity. P3Kα‐deficient genetic models (PI3KαDN and PI3Kα‐Mer‐Cre‐Mer) showed profound resistance to myocardial ischemia–reperfusion injury. In an ex vivo reperfusion protocol, PI3Kα‐deficient hearts had an 80% recovery of function compared with ≈10% recovery in the wild‐type. Using an in vivo reperfusion protocol, PI3Kα‐deficient hearts showed a 40% reduction in infarct size compared with wild‐type hearts. Lack of PI3Kα increased late Na + current, generating an influx of Na + , facilitating the lowering of mitochondrial Ca 2+ , thereby maintaining mitochondrial membrane potential and oxidative phosphorylation. Consistent with these functional differences, mitochondrial structure in PI3Kα‐deficient hearts was preserved following ischemia–reperfusion injury. Computer modeling predicted that PIP3, the product of PI3Kα action, can interact with the murine and human Na V 1.5 channels binding to the hydrophobic pocket below the selectivity filter and occluding the channel. Conclusions: Loss of PI3Kα protects from global ischemic–reperfusion injury linked to improved mitochondrial structure and function associated with increased late Na + current. Our results strongly support enhancement of mitochondrial function as a therapeutic strategy to minimize ischemia–reperfusion injury.

5 February 2026 in Cellular and Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
MAMaitha M. Alhajeri
Maitha M. Alhajeri
YAYara Abukhaled
Yara Abukhaled
RARayyah R. Alkhanjari
Rayyah R. Alkhanjari
WBWesam Bassiouni
Wesam Bassiouni
HAHana Al-Ali
Hana Al-Ali
KAKhaled S. Abd-Elrahman
Khaled S. Abd-Elrahman
Astrocytes, microglia, and oligodendrocytes, key neuroglial cell types, are essential for central nervous system (CNS) homeostasis, immune regulation, and neuronal support. In neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), glial dysfunction contributes to pathogenesis via chronic inflammation, synaptic disruption, oxidative stress, and impaired myelination. Growing evidence highlights the regulatory influence of sex hormones on glial function. These hormones modulate inflammatory tone, synaptic remodeling, and remyelination, potentially contributing to sex-based differences in disease incidence, progression, and treatment response. This review synthesizes current understanding of glial involvement in neurodegeneration and examines how gonadal hormones interact with astrocytes, microglia, and oligodendrocytes. By integrating glial biology with neuroendocrinology, we propose that hormone-glia interactions represent promising, personalized targets for sex-informed therapies in CNS disorders.

9 July 2026 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
WBWesam Bassiouni
Wesam Bassiouni
EYEmily Ye
Emily Ye
TCTash-Lynn L. Colson
Tash-Lynn L. Colson
SFStephen S.G. Ferguson
Stephen S.G. Ferguson
KAKhaled S. Abd-Elrahman
Khaled S. Abd-Elrahman